Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluourouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer - A prospective randomized study (vol 22, pg 593, 1999)

Cocconi, G Bisagni, G Bella, M Aato, L Anastasi, P Carpi, A Di Costanzo, F Frassoldati, A Mosconi, A Borrini, A Buzzi, P

G. Cocconi et al., Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluourouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer - A prospective randomized study (vol 22, pg 593, 1999), AM J CL ONC, 23(2), 2000, pp. CP3-CP3

1

Oncology

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

02773732 → ACNP

23

2

2000

CP3 - CP3

ISI

0277-3732(200004)23:2<CP3:COC(MA>2.0.ZU;2-3